Jasper Therapeutics, Inc. financial statements
Jasper Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 75.8M | 10-K |
| Cash and equivalents | USD 28.69M | 10-Q |
| Total debt | USD 1.24M | EODHD |
Jasper Therapeutics, Inc. financials on 6ix · Jasper Therapeutics, Inc. on 6ix